How to Buy Medline Stock
Medline Inc
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers.
Medline stock last closed at $32.99, up 2.74% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by N/A percentage points. Medline stock is currently +4.32% from its 52-week low of $31.63, and -35.16% from its 52-week high of $50.88.
As of Sep 16, 2026, there are 1.31B MDLN shares outstanding. The market value of MDLN is $43.37B. In the last 24 hours, 10.94M MDLN shares were traded.
How to Buy Medline Stock
Wondering how to invest in Medline stock? Here's how.
- Decide where to buy Medline stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Medline stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Choose your method of payment and add your info.
- Analyze Medline stock: The Medline ticker symbol is MDLN. Is Medline stock a good investment? Should you buy shares of MDLN? How do MDLN's underlying business fundamentals look? Do top analysts think Medline is a good buy? Why has MDLN's stock price moved recently? (Hint: Our stock research website can help you decide if MDLN is a good stock to buy).
- Execute your MDLN buy order: Decide if you will purchase MDLN shares at the current market price or use a limit order to buy MDLN stock at a particular price.
- Watch your investment in MDLN: Create a watchlist to the latest updates on your investment in Medline stock.
Step 1: Decide where to buy Medline stock
You need a brokerage account to access the NASDAQ market and buy MDLN stock.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Financial Services, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal info so you are able to buy MDLN stock today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start a new trading account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've opened your account on the greatest app to buy stocks, you can securely and quickly fund your account:
Watch the tutorial below for more details transferring funds into your investment account.
Step 4: Analyze Medline stock
After you have identified the best place to buy Medline stock, it's very important to evaluate their stock before you invest, so you truly wrap your head around the risk and upside.
Medline Metrics
MDLN Due Diligence Score
WallStreetZen was built to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on MDLN's stock page.
How is MDLN stock valued?
You can use many financial metrics, analyses, models, and charts to gauge MDLN's fair value.
Using relative valuations ratios:
- MDLN may be overvalued based on its P/B ratio of 3.75x, relative to Medical Instruments & Supplies industry P/B ratio of 3.23x
You can do additional valuation research on MDLN's stock here.
MDLN Financials at a glance
Positive Health Checks:
- MDLN profit margin has gone up from 0.3% to 2.3% in the past year.
- There are more short-term assets than short-term liabilities on the MDLN balance sheet.
Negative Health Checks:
- There are more long-term liabilities than short-term assets on the MDLN balance sheet.
- MDLN has a relatively high debt to equity ratio of 1.75.
Do Wall Street analysts think it's a good time to buy MDLN stock
Out of 14 Wall Street analysts who give ratings on MDLN, the consensus analyst rating on MDLN is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent MDLN Analyst Forecasts
Ryan Halsted, a top 37% analyst from RBC Capital maintains MDLN with a buy rating and lowers their MDLN price target from $53.00 to $46.00, on Aug 6, 2026.
Jailendra Singh, a bottom 1% analyst from Truist Securities maintains MDLN with a strong buy rating and lowers their MDLN price target from $56.00 to $47.00, on Aug 6, 2026.
Elizabeth Anderson, a top 16% analyst from Evercore ISI Group maintains MDLN with a buy rating and lowers their MDLN price target from $48.00 to $39.00, on Aug 6, 2026.
Rick Wise, a top 13% analyst from Stifel Nicolaus maintains MDLN with a strong buy rating and lowers their MDLN price target from $50.00 to $45.00, on Aug 6, 2026.
Eric Coldwell, a top 17% analyst from Baird maintains MDLN with a buy rating and lowers their MDLN price target from $57.00 to $45.00, on Jun 3, 2026.
You can dig deeper into what analysts are saying on the Medline stock forecast page.
Metrics for Advanced MDLN Traders
How is MDLN performing as a company?
Last year, MDLN revenue was $29.94B. Over the last 1 years, MDLN's revenue has increased by 12.12% per year. This was faster than the Medical Instruments & Supplies industry average of 10.17%.
Dive into MDLN's earnings and revenue performance here.
What are MDLN insiders up to?
In the past year, insiders at MDLN have sold more shares than they have bought.
Gic Private Ltd, 10% Owner of MDLN, was the latest MDLN insider to sell. They sold $3,580,000.00 worth of MDLN stock on Aug 14, 2026.
Get more info about who owns MDLN stock here.
Can I get consistent income from MDLN stock?
No, Medline doesn't provide an income stream by paying out dividends.
MDLN Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your MDLN buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount limit, place a limit order.
Click the Open button and eToro will execute your order.
If you need more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Watch your investment in MDLN
Now that you own some MDLN stock, you'll want to stay up-to-date on your investment.
Put MDLN on a watchlist to see the latest developments about your MDLN stock.
MDLN Feed
How to Buy Stock in Medline
To reiterate, here are the 6 steps to buy stock in Medline:
- Decide where to buy Medline stock
- Open your brokerage account
- Put funds into your investment account
- Analyze Medline stock
- Execute your MDLN buy order
- Watch your investment in MDLN
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your new investment in Medline, create your watchlist below.
More Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.